Synchrony Financial
SYF - NYSE - $73.14 ▼ -%1.16
-
Earnings Tue 21 Jul

Synchrony opens the
books on Tuesday evening.

3 analysts' median target is $93[FMP target], stock is $73, +27.2% upside potential. After Q1 +2.3% EPS beat[FMP earnings], the stock moved +1.4%.

summary below
Quick Take - in 40 seconds
A
BUY Council 5/6 - Moonshot 56

A = MoonshotScore 56[9-pillar formula] + Council 5/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].

Q4 consensus: revenue $3.7B[FMP est], EPS $2.10[FMP est]. 5 consecutive quarters of beat[FMP earnings].

$2.10 EPS Estimate Last year $2.07 - -16% YoY YoY
5 Beat Streak Expectations beaten consecutively for the last 5 quarters

Q1 EPS +2.3% beat[FMP] but the stock +1.4% D+1[FMP D+1]. Brian Wenzel promised $0 CapEx + a sequential decline in Q4 during the Q1 earnings call[Brian Wenzel capex transcript].

Watchlist

6 metrics stand out this quarter.

$9.10 Expectation / Guide

Eps Guidance

eps_guidance

Synchrony remains on track to deliver between $9.10 and $9.50 in diluted earnings per share for 2026, with consistent risk-adjusted growth and strong capital generation.

"Putting all these elements together, Synchrony remains on track to deliver between $9.10 and $9.50 in diluted earnings per share, while also executing across key strategic priorities to deliver consistent risk-adjusted growth and strong capital generation."

- Brian Wenzel - Q1 FY26 Earnings Call - April 21, 2026
$43 billion Investor Focus

Purchase Volume Growth

purchase_volume_growth

Synchrony achieved a record first quarter purchase volume of $43 billion, a 6% increase.

"Synchrony started the year with strong momentum and delivered first quarter financial results that included record first quarter purchase volume of $43 billion, reflecting the enduring appeal of Synchrony's multiproduct suite."

- Brian Doubles - Q1 FY26 Earnings Call - April 21, 2026
4% Expectation / Guide

Rsa Guidance

rsa_guidance

Synchrony expects RSAs to increase as program performance strengthens, but remain within its long-term range of 4% to 4.5% of average receivables.

"As program performance strengthens due to higher net interest income and lower losses compared to last year, we continue to expect RSAs to increase but remain within our long-term range of 4% to 4.5% of average receivables."

- Brian Wenzel - Q1 FY26 Earnings Call - April 21, 2026
$100 billion Investor Focus

Loan Receivables Growth

loan_receivables_growth

Synchrony achieved a positive inflection in ending loan receivables with an increase of approximately $477 million at the end of the first quarter.

"Ending loan receivables were flat at $100 billion, though we did achieve a positive inflection in ending loan receivables with an increase of approximately $477 million at the end of the first quarter."

- Brian Wenzel - Q1 FY26 Earnings Call - April 21, 2026
5.5% Expectation / Guide

Net Charge Off Guidance

net_charge_off_guidance

Synchrony expects net charge-offs to be less than 5.5% for the full year 2026.

"We expect our net charge-offs to be less than 5.5% for the full year, and we remain focused on our disciplined approach to underwriting our business."

- Brian Wenzel - Q1 FY26 Earnings Call - April 21, 2026
50 Investor Focus

Payment Rate Increase

payment_rate_increase

Synchrony's payment rate increased approximately 50 basis points compared to last year.

"Meanwhile, payment rate increased approximately 50 basis points compared to last year."

- Brian Doubles - Q1 FY26 Earnings Call - April 21, 2026

Stock Expert AI - Methodology

Do our 9 pillars, 7 perspectives, and Munger lens point in the same direction?

Council Score 5 / 6 Bullish

6 investor frameworks. 5 bullish (Ray Dalio, Ken Griffin, Klarman, Buffett, Munger), 0 bearish (none), 1 neutral (Jim Simons).

How is it calculated? ->
Ray Dalio macro - target upside +27.2%
Ken Griffin flow - 50d MA above
Jim Simons quant - RSI 47
Klarman value - target upside +27.2%
Buffett quality - ROE score 5/5
Munger valuation - target upside +27.2%
Munger's Mindset character & balance sheet lens
Undervalued

Quality business, discounted price.

How is it calculated? ->
Financial HealthStrong
Margin of SafetyStrong
Interest CoverageAdequate
ROIC vs WACCHealthy
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
46.7 RSI 46.7 balanced, 50d above
MACD
+3.30 price above 50d - support positive
50d MA
$71 stock 3.3% above - short-term support
200d MA
$74 stock 1.5% below - long-term pressure
Volume (10d)
+11% increase - pre-earnings positioning
Resistance
$93
Analyst median target - upgrade trigger if broken
Current
$73
Pre-earnings position
Support
$63
Invalidation - close below this is a technical breakdown
Pattern
Range
$63-$93 band - earnings breakout/breakdown trigger

Past Performance

Synchrony's last 8 quarters: 5 consecutive beats.

BEAT
Q2 FY25
$2.50 vs $1.82 est - +2.0%
BEAT
Q3 FY25
$2.86 vs $2.26 est - -2.9%
BEAT
Q4 FY25
$2.07 vs $2.05 est - +0.6%
BEAT
Q1 FY26
$2.27 vs $2.22 est - +1.4%

Q1 (April 21, 2026): EPS $2.27 vs $2.22 est[FMP], +2.3% beat. D+1 movement: +1.4%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.

Three scenarios: what could happen?

EPS < $2.04 (no guidance)

Q1: EPS $2.27 vs $2.22 beat[FMP], stock +1.4% D+1[FMP].

Backlog concentration

No RPO/backlog concentration disclosed in Q1 earnings call.

CapEx shock

Q1 CapEx $0[FMP cashflow]. Q1 op margin 16.3%[FMP op margin] - this level in Q4 is sensitive to CapEx revision risk.

Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q4 EPS > $2.10 + CapEx discipline
Threshold: EPS > $2.10[FMP est].
Target: Break above median target $93[FMP target]; high target $100[FMP] upper bound.
Scenario B - In-Line
EPS approx $2.10 + CapEx < $0
Threshold: EPS approx $2.10[FMP est], Q4 CapEx < $0[FMP].
Target: Consolidation in the band between current $73[FMP] and median $93[FMP].
Scenario C - Miss
EPS < $2.04 or CapEx >= $0
Threshold: EPS < $2.04[FMP estx0.97].
Target: Current $73 below SMA200 $74[FMP], if rejection continues, $63[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.

Market Outlook

What do 3 analysts say?

Wall Street Consensus
$93
12-month median target price (+27.2% upside potential)
15
BUY
8
HOLD
0
SELL
Risk Management
$63
Invalidation level - critical support threshold
$71 - 50-day MA (above, +3.3%)
$74 - 200-day MA (below, -1.5%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - SYF Q4 FY26
A

You read it in 5 minutes. When the numbers come out on Tuesday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Tuesday evening. The framework is ready on this page: Q4 EPS threshold $2.10[FMP], CapEx threshold "below $0"[Brian Wenzel]. Two anchors, three scenarios.

Comparison Stock Expert AI Pro $24/month ($240/year), 77% cheaper than the total of three earnings-tracking tools ($1,059/year -> $240/year).

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI Pro: $24/month ($240/year). Council 7-lens analysis + MoonshotScore 9-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

Jul 21, 2026EARNINGSQ4 FY26 results (after market close) + earnings call
Jul 22, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Sep 4, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Oct 21, 2026EARNINGSQ1 FY27 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the SYF earnings preview cover?

This SYF (SYF) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in SYF earnings?

Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.